Control (n = 71) | MI (DM−) (n = 113) | MI (DM+) (n = 95) | |
---|---|---|---|
Baseline characteristics | |||
Age, years | 58 ± 258.95 | 58.08 ± 1.88 | 60.76 ± 77 |
Male, n (%) | 55 (77.46%) | 97 (85.84%) | 85 (89.47%) |
BMI, kg/m2 | 23.31 (21.78, 25.27) | 24.37 (22.31, 26.51) | 25.16 (22.60, 27.22) |
Systolic blood pressure, mmHg | 127.83 ± 16.19 | 122.99 ± 19.31 | 126.90 ± 22.44 |
Diastolic blood pressure, mmHg | 76.58 ± 10.16 | 75.17 ± 13.18 | 77.45 ± 11.83 |
Heart rate, bpm | 70.69 (63.59, 78.97) | 70.44 (61.79, 80.22) | 73.19 (65.81, 80.97) |
Cardiovascular risk factors | |||
Previous/current smoker, n (%) | – | 77 (68.14%) | 60 (63.16%) |
Hyperlipidemia | – | 65 (57.52%) | 55 (57.89%) |
Hypertension | – | 50 (44.25%) | 57 (60.00%) |
Pervious PCI, n (%) | – | 47 (41.59%) | 43 (45.26%) |
Pervious GABG n (%) | 0 | 2 (2.11%) | |
NYHA functional class, n | |||
I | – | 33 (29.20%) | 12 (12.63%)b |
II | – | 41 (36.28%) | 45 (47.37%) |
III | – | 33 (29.20%) | 31 (32.63%) |
IV | – | 6 (5.31%) | 7 (7.37%) |
Culprit vessel n (%) | |||
Left main | – | 3 (2.65%) | 2 (2.11%) |
Left anterior descending | – | 46 (40.71%) | 41 (43.16%) |
Left circumflex | – | 23 (20.35%) | 18 (18.95%) |
Right coronary artery | – | 41 (36.28%) | 34 (35.79%) |
Number of diseased vessels n (%) | |||
1 | 58 (51.33%) | 36 (37.89%) | |
2 | 34 (30.09%) | 34 (35.79%) | |
3 | 17 (15.04%) | 23 (24.21%) | |
HbA1c, % | 5.75 ± 0.46 | 7.90 (7.00, 8.90)b | |
Triglycerides, mmol/L | 1.43 (0.95, 1.83) | 1.44 (1.04, 2.27) | 1.43 (0.93, 2.01) |
Total cholesterol, mmol/L | 4.33 ± 0.54 | 3.55 (3.19, 3.91) | 3.24 (2.89, 3.98) |
HDL, mmol/L | 1.32 ± 0.34 | 1.04 (0.84, 1.24) | 1.00 (0.82, 1.16) |
LDL, mmol/L | 2.56 ± 0.58 | 1.26 (1.16, 1.96) | 1.86 (1.51, 2.39) |
eGFR, mL/min/1.73m2 | 100.32 (87.00, 110.85) | 84.97 (72.37, 96.21) | 80.31 (65.69, 94.55) |
Troponin, ng/L | 14.20 (9.40, 28.60) | 20.90 (11.20, 39.10) | |
NT-proBNP | – | 311.00 (167.50, 766.00) | 687.00 (155.50, 1916.50)b |
Concomitant medication, n (%) | |||
Aspirin, n (%) | – | 106 (93.81%) | 90 (94.74%) |
ß-blockers, n (%) | – | 92 (81.42%) | 78 (82.11%) |
ACEI/ARB, n (%) | – | 68 (60.18%) | 65 (68.42%) |
Diuretics | – | 46 (40.71%) | 36 (37.89%) |
Calcium-channel blocker | – | 84 (74.34%) | 74 (77.89%) |
Insulin | – | 12 (10.62%) | 56 (58.95%) |
Statin, n (%) | – | 89 (78.76%) | 89 (93.68%) |